Steatohepatitis: a tale of two "hits"?
- PMID: 9547102
- DOI: 10.1016/s0016-5085(98)70599-2
Steatohepatitis: a tale of two "hits"?
Similar articles
-
Nonalcoholic steatohepatitis.Ann Intern Med. 1997 Sep 1;127(5):410; author reply 411. doi: 10.7326/0003-4819-127-5-199709010-00014. Ann Intern Med. 1997. PMID: 9273836 No abstract available.
-
Tamoxifen-induced steatohepatitis.Ann Intern Med. 1996 May 1;124(9):855-6. doi: 10.7326/0003-4819-124-9-199605010-00015. Ann Intern Med. 1996. PMID: 8610959 No abstract available.
-
The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis.Hepatology. 2001 Jan;33(1):311-2. doi: 10.1053/jhep.2001.0330311. Hepatology. 2001. PMID: 11124851 No abstract available.
-
[Role of mitochondria in drug-induced hepatotoxicity].Gastroenterol Clin Biol. 1998 Jan;22(1):59-72. Gastroenterol Clin Biol. 1998. PMID: 9762168 Review. French. No abstract available.
-
Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity?Liver. 1999 Aug;19(4):263-4. doi: 10.1111/j.1478-3231.1999.tb00047.x. Liver. 1999. PMID: 10459622 Review. No abstract available.
Cited by
-
Non-alcoholic fatty liver disease: pathogenesis and models.Am J Transl Res. 2024 Feb 15;16(2):387-399. eCollection 2024. Am J Transl Res. 2024. PMID: 38463579 Free PMC article. Review.
-
The ABC of Immune-Mediated Hepatitis during Immunotherapy in Patients with Cancer: From Pathogenesis to Multidisciplinary Management.Cancers (Basel). 2024 Feb 15;16(4):795. doi: 10.3390/cancers16040795. Cancers (Basel). 2024. PMID: 38398187 Free PMC article. Review.
-
Does myo-inositol supplementation influence oxidative stress biomarkers in patients with non-alcoholic fatty liver disease?Food Sci Nutr. 2023 Dec 6;12(2):1279-1289. doi: 10.1002/fsn3.3842. eCollection 2024 Feb. Food Sci Nutr. 2023. PMID: 38370063 Free PMC article.
-
Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications.Front Immunol. 2024 Jan 30;15:1336493. doi: 10.3389/fimmu.2024.1336493. eCollection 2024. Front Immunol. 2024. PMID: 38352880 Free PMC article. Review.
-
The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review.Med Pharm Rep. 2024 Jan;97(1):12-25. doi: 10.15386/mpr-2629. Epub 2024 Jan 29. Med Pharm Rep. 2024. PMID: 38344336 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
